Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 305

1.

Refining the role of carpal tunnel syndrome in cardiac amyloidosis.

Westin O, Fosbøl E, Gustafsson F.

Eur J Heart Fail. 2020 Feb 18. doi: 10.1002/ejhf.1763. [Epub ahead of print] No abstract available.

PMID:
32069519
2.

Invasive haemodynamics in de novo everolimus vs. calcineurin inhibitor heart transplant recipients.

Bergh N, Gude E, Bartfay SE, K Andreassen A, Arora S, Dahlberg P, Dellgren G, Gullestad L, Gustafsson F, Karasson K, Rådegran G, Bollano E, Andersson B.

ESC Heart Fail. 2020 Feb 14. doi: 10.1002/ehf2.12608. [Epub ahead of print]

3.

Favorable five-year outcomes for heart failure diagnosed in younger patients without severe comorbidity.

Madelaire C, Gustafsson F, Stevenson LW, Kristensen SL, Køber L, Andersen J, D'Souza M, Torp-Pedersen C, Gislason G, Schou M.

Int J Cardiol. 2020 Jan 23. pii: S0167-5273(19)34977-0. doi: 10.1016/j.ijcard.2020.01.055. [Epub ahead of print]

PMID:
32005452
4.

Evaluation of an electronic, patient-focused management system aimed at preventing cytomegalovirus disease following solid organ transplantation.

Ekenberg C, da Cunha-Bang C, Lodding IP, Sørensen SS, Sengeløv H, Perch M, Rasmussen A, Gustafsson F, Wareham NE, Kirkby N, Kjaer J, Helleberg M, Reekie J, Lundgren JD.

Transpl Infect Dis. 2020 Jan 30:e13252. doi: 10.1111/tid.13252. [Epub ahead of print]

PMID:
31997565
5.

Right ventricular transverse displacement increases following cardiac surgery: possibly compensating loss in tricuspid annular plane systolic excursion (TAPSE).

Korshin A, Grønlykke L, Holmgaard F, Kjøller SM, Gustafsson F, Nilsson JC, Ravn HB.

J Clin Monit Comput. 2020 Jan 25. doi: 10.1007/s10877-020-00466-2. [Epub ahead of print]

PMID:
31983013
6.

Mild acute cellular rejection and development of cardiac allograft vasculopathy assessed by intravascular ultrasound and coronary angiography in heart transplant recipients-a SCHEDULE trial substudy.

Nelson LM, Andreassen AK, Arora S, Andersson B, Gude E, Eiskjaer H, Rådegran G, Dellgren G, Gullestad L, Gustafsson F.

Transpl Int. 2020 Jan 20. doi: 10.1111/tri.13577. [Epub ahead of print]

PMID:
31958178
7.

[Unexplained dyspnoea].

Wolsk E, Rossing K, Carlsen J, Perch M, Gustafsson F.

Ugeskr Laeger. 2019 Dec 30;182(1). pii: V07190381. Danish.

PMID:
31928623
8.

The Effect of Common Interventions in the Intensive Care Unit on Right Ventricular Function After Cardiac Surgery-An Intervention Study.

Grønlykke L, Korshin A, Gustafsson F, Nilsson JC, Ravn HB.

J Cardiothorac Vasc Anesth. 2019 Dec 6. pii: S1053-0770(19)31215-7. doi: 10.1053/j.jvca.2019.11.043. [Epub ahead of print]

PMID:
31919003
9.

First Let's Try… Will the Success of New Therapies Paradoxically Challenge Outcomes in Advanced Heart Failure?

Gustafsson F.

Circ Heart Fail. 2020 Jan;13(1):e006610. doi: 10.1161/CIRCHEARTFAILURE.119.006610. Epub 2019 Dec 30. No abstract available.

PMID:
31884809
10.

Performance of Prognostic Risk Scores in Heart Failure Patients: Do Sex Differences Exist?

Vishram-Nielsen JKK, Foroutan F, Ross HJ, Gustafsson F, Alba AC.

Can J Cardiol. 2020 Jan;36(1):45-53. doi: 10.1016/j.cjca.2019.08.021. Epub 2019 Aug 22.

PMID:
31874750
11.

Pulmonary artery pulsatility index: physiological basis and clinical application.

Lim HS, Gustafsson F.

Eur J Heart Fail. 2020 Jan;22(1):32-38. doi: 10.1002/ejhf.1679. Epub 2019 Nov 28. Review.

PMID:
31782244
12.

Design of a randomised controlled trial of the effects of empagliflozin on myocardial perfusion, function and metabolism in type 2 diabetes patients at high cardiovascular risk (the SIMPLE trial).

Jürgens M, Schou M, Hasbak P, Kjær A, Wolsk E, Zerahn B, Wiberg M, Brandt NH, Gæde PH, Rossing P, Faber J, Inzucchi S, Gustafsson F, Kistorp CM.

BMJ Open. 2019 Nov 27;9(11):e029098. doi: 10.1136/bmjopen-2019-029098.

13.

Effects of Interatrial Shunt on Pulmonary Vascular Function in Heart Failure With Preserved Ejection Fraction.

Obokata M, Reddy YNV, Shah SJ, Kaye DM, Gustafsson F, Hasenfuβ G, Hoendermis E, Litwin SE, Komtebedde J, Lam C, Burkhoff D, Borlaug BA.

J Am Coll Cardiol. 2019 Nov 26;74(21):2539-2550. doi: 10.1016/j.jacc.2019.08.1062.

PMID:
31753198
14.

Assessment of Predictors of Left Atrial Volume Response to a Transcatheter InterAtrial Shunt Device (from the REDUCE LAP-HF Trial).

Hanff TC, Kaye DM, Hayward CS, Post MC, Malek F, Hasenfuβ G, Gustafsson F, Burkhoff D, Shah SJ, Litwin SE, Kahwash R, Hummel SL, Borlaug BA, Solomon SD, Lam CSP, Komtebedde J, Silvestry FE; REDUCE LAP-HF study investigators, and research staff.

Am J Cardiol. 2019 Dec 15;124(12):1912-1917. doi: 10.1016/j.amjcard.2019.09.019. Epub 2019 Sep 26.

PMID:
31653352
15.

MR-proANP Associated with Body Mass Index in Patients with Anorexia Nervosa.

Goetze JP, Gustafsson F, Pedersen O, Støving RK.

J Appl Lab Med. 2019 Jul;4(1):132-134. doi: 10.1373/jalm.2018.028290. Epub 2019 Jan 22. No abstract available.

PMID:
31639717
16.

Occult cardiac amyloidosis?

Westin O, Gustafsson F, Fosbøl E.

Aging (Albany NY). 2019 Oct 19;11(20):8739-8740. doi: 10.18632/aging.102383. Epub 2019 Oct 19. No abstract available.

17.

A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus.

Farmakis D, Agostoni P, Baholli L, Bautin A, Comin-Colet J, Crespo-Leiro MG, Fedele F, García-Pinilla JM, Giannakoulas G, Grigioni F, Gruchała M, Gustafsson F, Harjola VP, Hasin T, Herpain A, Iliodromitis EK, Karason K, Kivikko M, Liaudet L, Ljubas-Maček J, Marini M, Masip J, Mebazaa A, Nikolaou M, Ostadal P, Põder P, Pollesello P, Polyzogopoulou E, Pölzl G, Tschope C, Varpula M, von Lewinski D, Vrtovec B, Yilmaz MB, Zima E, Parissis J.

Int J Cardiol. 2019 Dec 15;297:83-90. doi: 10.1016/j.ijcard.2019.09.005. Epub 2019 Sep 6.

18.

"Risk of de novo or secondary cancer after solid organ or allogeneic haematopoietic stem cell transplantation".

Wareham NE, Li Q, Sengeløv H, Da Cunha-Bang C, Gustafsson F, Heilmann C, Perch M, Rasmussen A, Sørensen SS, Mocroft A, Lundgren JD.

J Cancer Res Clin Oncol. 2019 Dec;145(12):3125-3135. doi: 10.1007/s00432-019-03039-2. Epub 2019 Nov 5.

PMID:
31587105
19.

Duration of Heart Failure and Effect of Defibrillator Implantation in Patients With Nonischemic Systolic Heart Failure.

Elming MB, Thøgersen AM, Videbæk L, Bruun NE, Eiskjær H, Haarbo J, Egstrup K, Gustafsson F, Hastrup Svendsen J, Høfsten DE, Pehrson S, Nielsen JC, Køber L, Thune JJ.

Circ Heart Fail. 2019 Sep;12(9):e006022. doi: 10.1161/CIRCHEARTFAILURE.119.006022. Epub 2019 Sep 10.

PMID:
31500444
20.

Outcome after heart-lung or lung transplantation in patients with Eisenmenger syndrome.

Hjortshøj CS, Gilljam T, Dellgren G, Pentikäinen MO, Möller T, Jensen AS, Turanlahti M, Thilén U, Gustafsson F, Søndergaard L.

Heart. 2020 Jan;106(2):127-132. doi: 10.1136/heartjnl-2019-315345. Epub 2019 Aug 21.

21.

Interplay of pump design elements and bleeding predilection-Mechanisms for a forward momentum.

Gustafsson F, Netuka I.

J Heart Lung Transplant. 2019 Aug;38(8):817-819. doi: 10.1016/j.healun.2019.06.002. Epub 2019 Jun 19. No abstract available.

PMID:
31352997
22.

Relationship between invasive hemodynamics and liver function in advanced heart failure.

Vishram-Nielsen JKK, Deis T, Balling L, Sabbah M, Boesgaard S, Rossing K, Wolsk E, Gustafsson F.

Scand Cardiovasc J. 2019 Oct;53(5):235-246. doi: 10.1080/14017431.2019.1646972. Epub 2019 Jul 30.

PMID:
31327253
23.

Association of Carpal Tunnel Syndrome With Amyloidosis, Heart Failure, and Adverse Cardiovascular Outcomes.

Fosbøl EL, Rørth R, Leicht BP, Schou M, Maurer MS, Kristensen SL, Kober L, Gustafsson F.

J Am Coll Cardiol. 2019 Jul 9;74(1):15-23. doi: 10.1016/j.jacc.2019.04.054.

PMID:
31272537
24.

Immune function as predictor of infectious complications and clinical outcome in patients undergoing solid organ transplantation (the ImmuneMo:SOT study): a prospective non-interventional observational trial.

Drabe CH, Sørensen SS, Rasmussen A, Perch M, Gustafsson F, Rezahosseini O, Lundgren JD, Ostrowski SR, Nielsen SD.

BMC Infect Dis. 2019 Jul 3;19(1):573. doi: 10.1186/s12879-019-4207-9.

25.

Sound analysis of the magnetically levitated left ventricular assist device HeartMate 3.

Sundbom P, Roth M, Granfeldt H, Karlsson DM, Ahn H, Gustafsson F, Dellgren G, Hubbert L.

Int J Artif Organs. 2019 Dec;42(12):717-724. doi: 10.1177/0391398819857443. Epub 2019 Jun 28.

26.

Reply: Physical Activity and Fitness in Heart Failure With Preserved Ejection Fraction: Ready for Prime Time?

Wolsk E, Gustafsson F.

JACC Heart Fail. 2019 Jul;7(7):634-635. doi: 10.1016/j.jchf.2019.04.009. No abstract available.

PMID:
31248576
27.

Burden and Causes of Hospital Admissions in Heart Failure During the Last Year of Life.

Madelaire C, Gustafsson F, Kristensen SL, D'Souza M, Stevenson LW, Kober L, Torp-Pedersen C, Gislason G, Schou M.

JACC Heart Fail. 2019 Jul;7(7):561-570. doi: 10.1016/j.jchf.2019.03.018.

PMID:
31248567
28.

Empagliflozin in heart failure patients with reduced ejection fraction: a randomized clinical trial (Empire HF).

Jensen J, Omar M, Kistorp C, Poulsen MK, Tuxen C, Gustafsson I, Køber L, Gustafsson F, Fosbøl E, Bruun NE, Videbæk L, Frederiksen PH, Møller JE, Schou M.

Trials. 2019 Jun 21;20(1):374. doi: 10.1186/s13063-019-3474-5.

29.

Hemodynamic Response to Rapid Saline Infusion Compared with Exercise in Healthy Participants Aged 20-80 Years.

Andersen MJ, Wolsk E, Bakkestrøm R, Thomsen JH, Balling L, Dahl JS, Gustafsson F, Møller JE, Hassager C.

J Card Fail. 2019 Nov;25(11):902-910. doi: 10.1016/j.cardfail.2019.06.004. Epub 2019 Jun 17.

PMID:
31220623
30.

Risk Factors for Failure of Primary (Val)ganciclovir Prophylaxis Against Cytomegalovirus Infection and Disease in Solid Organ Transplant Recipients.

Khurana MP, Lodding IP, Mocroft A, Sørensen SS, Perch M, Rasmussen A, Gustafsson F, Lundgren JD.

Open Forum Infect Dis. 2019 May 8;6(6):ofz215. doi: 10.1093/ofid/ofz215. eCollection 2019 Jun.

31.

2019 EACTS Expert Consensus on long-term mechanical circulatory support.

Potapov EV, Antonides C, Crespo-Leiro MG, Combes A, Färber G, Hannan MM, Kukucka M, de Jonge N, Loforte A, Lund LH, Mohacsi P, Morshuis M, Netuka I, Özbaran M, Pappalardo F, Scandroglio AM, Schweiger M, Tsui S, Zimpfer D, Gustafsson F.

Eur J Cardiothorac Surg. 2019 Aug 1;56(2):230-270. doi: 10.1093/ejcts/ezz098.

32.

Sacubitril/valsartan augments postprandial plasma concentrations of active GLP-1 when combined with sitagliptin in men.

Wewer Albrechtsen NJ, Mark PD, Terzic D, Hansen LH, Andersen UØ, Hartmann B, Carr RD, Gustafsson F, Deacon CF, Holst JJ, Goetze JP, Plomgaard P.

J Clin Endocrinol Metab. 2019 May 10. pii: jc.2019-00515. doi: 10.1210/jc.2019-00515. [Epub ahead of print]

PMID:
31074791
33.

Severe loss of right ventricular longitudinal contraction occurs after cardiopulmonary bypass in patients with preserved right ventricular output.

Grønlykke L, Korshin A, Holmgaard F, Kjøller SM, Gustafsson F, Nilsson JC, Ravn HB.

Int J Cardiovasc Imaging. 2019 Sep;35(9):1661-1670. doi: 10.1007/s10554-019-01616-7. Epub 2019 May 2.

PMID:
31049752
34.

Incidence Rates and Risk Factors of Clostridioides difficile Infection in Solid Organ and Hematopoietic Stem Cell Transplant Recipients.

Ilett EE, Helleberg M, Reekie J, Murray DD, Wulff SM, Khurana MP, Mocroft A, Daugaard G, Perch M, Rasmussen A, Sørensen SS, Gustafsson F, Frimodt-Møller N, Sengeløv H, Lundgren J.

Open Forum Infect Dis. 2019 Feb 19;6(4):ofz086. doi: 10.1093/ofid/ofz086. eCollection 2019 Apr.

35.

A Tutorial on Auditory Attention Identification Methods.

Alickovic E, Lunner T, Gustafsson F, Ljung L.

Front Neurosci. 2019 Mar 19;13:153. doi: 10.3389/fnins.2019.00153. eCollection 2019.

36.

Prevalence of heart failure and other risk factors among first-degree relatives of women with peripartum cardiomyopathy.

Christiansen MN, Køber L, Torp-Pedersen C, Smith JG, Gustafsson F, Vejlstrup NG, Damm P, Johansen M, Andersson C, Ersbøll AS.

Heart. 2019 Jul;105(14):1057-1062. doi: 10.1136/heartjnl-2018-314552. Epub 2019 Mar 25.

PMID:
30910822
37.

Everolimus Initiation With Early Calcineurin Inhibitor Withdrawal in De Novo Heart Transplant Recipients: Long-term Follow-up From the Randomized SCHEDULE Study.

Gustafsson F, Andreassen AK, Andersson B, Eiskjær H, Rådegran G, Gude E, Jansson K, Solbu D, Karason K, Arora S, Dellgren G, Gullestad L; SCHEDULE (Scandinavian heart transplant everolimus de novo study with early calcineurin inhibitors avoidance) Investigators*.

Transplantation. 2020 Jan;104(1):154-164. doi: 10.1097/TP.0000000000002702.

PMID:
30893292
38.

Central and Peripheral Determinants of Exercise Capacity in Heart Failure Patients With Preserved Ejection Fraction.

Wolsk E, Kaye D, Komtebedde J, Shah SJ, Borlaug BA, Burkhoff D, Kitzman DW, Lam CSP, van Veldhuisen DJ, Ponikowski P, Petrie MC, Hassager C, Møller JE, Gustafsson F.

JACC Heart Fail. 2019 Apr;7(4):321-332. doi: 10.1016/j.jchf.2019.01.006. Epub 2019 Mar 6.

PMID:
30852235
39.

The impact of implantable cardioverter-defibrillator implantation on health-related quality of life in the DANISH trial.

Bundgaard JS, Thune JJ, Nielsen JC, Videbæk R, Haarbo J, Bruun NE, Videbæk L, Aagaard D, Korup E, Jensen G, Hildebrandt P, Steffensen FH, Eiskjær H, Brandes A, Thøgersen AM, Melchior TM, Pedersen OD, Gustafsson F, Egstrup K, Hassager C, Svendsen JH, Høfsten DE, Torp-Pedersen C, Pedersen SS, Pehrson S, Køber L, Mogensen UM.

Europace. 2019 Jun 1;21(6):900-908. doi: 10.1093/europace/euz018.

PMID:
30796456
40.

Relation between invasive hemodynamics and measured glomerular filtration rate by 51Cr-EDTA clearance in advanced heart failure.

Deis T, Balling L, Boesgaard S, Rossing K, Schou M, Oturai P, Wolsk E, Gustafsson F.

Scand J Clin Lab Invest. 2019 May;79(3):194-201. doi: 10.1080/00365513.2019.1576221. Epub 2019 Feb 20.

PMID:
30784338
41.

Lung diffusion capacity in advanced heart failure: relation to central haemodynamics and outcome.

Deis T, Balling L, Rossing K, Wolsk E, Perch M, Gustafsson F.

ESC Heart Fail. 2019 Apr;6(2):379-387. doi: 10.1002/ehf2.12401. Epub 2019 Feb 19.

42.

Continuous-flow LVADs in the Nordic countries: complications and mortality and its predictors.

Braun OÖ, Nilsson J, Gustafsson F, Dellgren G, Fiane AE, Lemström K, Hubbert L, Hellgren L, Lund LH.

Scand Cardiovasc J. 2019 Feb;53(1):14-20. doi: 10.1080/14017431.2019.1583365. Epub 2019 Mar 5.

PMID:
30776923
43.

Effect of High-Intensity Interval Training in De Novo Heart Transplant Recipients in Scandinavia.

Nytrøen K, Rolid K, Andreassen AK, Yardley M, Gude E, Dahle DO, Bjørkelund E, Relbo Authen A, Grov I, Philip Wigh J, Have Dall C, Gustafsson F, Karason K, Gullestad L.

Circulation. 2019 May 7;139(19):2198-2211. doi: 10.1161/CIRCULATIONAHA.118.036747. Erratum in: Circulation. 2019 Oct 22;140(17):e737.

PMID:
30773030
44.

Effect of Heart Rate Reserve on Exercise Capacity in Patients Treated with a Continuous Left Ventricular Assist Device.

Mirza KK, Cuomo K, Jung MH, Russell SD, Gustafsson F.

ASAIO J. 2020 Feb;66(2):160-165. doi: 10.1097/MAT.0000000000000955.

PMID:
30688691
45.

The Potential Role of Transcatheter Heart Valve Interventions in Heart Failure Treatment.

Søndergaard L, Gustafsson F.

JACC Cardiovasc Interv. 2019 Jan 28;12(2):166-168. doi: 10.1016/j.jcin.2018.11.003. Epub 2018 Dec 26. No abstract available.

46.

Repetitive levosimendan treatment in the management of advanced heart failure.

Oliva F, Comin-Colet J, Fedele F, Fruhwald F, Gustafsson F, Kivikko M, Borbély A, Pölzl G, Tschöpe C.

Eur Heart J Suppl. 2018 Dec;20(Suppl I):I11-I20. doi: 10.1093/eurheartj/suy040. Epub 2018 Nov 2.

47.

Computed Tomography-Estimated Right Ventricular Function and Exercise Capacity in Patients with Continuous-Flow Left Ventricular Assist Devices.

Mirza KK, Jung MH, Sigvardsen PE, Kofoed KF, Elming MB, Rossing K, Gustafsson F.

ASAIO J. 2020 Jan;66(1):8-16. doi: 10.1097/MAT.0000000000000925.

PMID:
30489293
48.

Right Ventricular and Pulmonary Vascular Function are Influenced by Age and Volume Expansion in Healthy Humans.

Wolsk E, Bakkestrøm R, Kristensen CB, Aagaard Myhr K, Thomsen JH, Balling L, Andersen MJ, Dahl JS, Shah SJ, Gustafsson F, Hassager C, Møller JE.

J Card Fail. 2019 Jan;25(1):51-59. doi: 10.1016/j.cardfail.2018.11.013. Epub 2018 Nov 22.

PMID:
30472282
49.

Levosimendan in Acute and Advanced Heart Failure: an Expert Perspective on Posology and Therapeutic Application.

Bouchez S, Fedele F, Giannakoulas G, Gustafsson F, Harjola VP, Karason K, Kivikko M, von Lewinski D, Oliva F, Papp Z, Parissis J, Pollesello P, Pölzl G, Tschöpe C.

Cardiovasc Drugs Ther. 2018 Dec;32(6):617-624. doi: 10.1007/s10557-018-6838-2. Review.

50.

Repetitive levosimendan infusions for patients with advanced chronic heart failure in the vulnerable post-discharge period.

Pölzl G, Allipour Birgani S, Comín-Colet J, Delgado JF, Fedele F, García-Gonzáles MJ, Gustafsson F, Masip J, Papp Z, Störk S, Ulmer H, Vrtovec B, Wikström G, Altenberger J.

ESC Heart Fail. 2019 Feb;6(1):174-181. doi: 10.1002/ehf2.12366. Epub 2018 Oct 30.

Supplemental Content

Loading ...
Support Center